StemSynergy Therapeutics Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 5

StemSynergy Therapeutics General Information

Description

Operator of a medical biotechnology company intended to develop therapeutic drugs for cancer treatments. The company specializes in the research and discovery of medications that target biomolecules and cellular processes by targeting the cancer stem/initiating cell (CSC) populations, helping the healthcare industry eliminate tumor growth.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1951 NorthWest 7th Avenue
  • Suite 300
  • Miami, FL 33136
  • United States
+1 (305)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 1951 NorthWest 7th Avenue
  • Suite 300
  • Miami, FL 33136
  • United States
+1 (305)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

StemSynergy Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC Completed Pre-Clinical Trials
12. Grant 05-Apr-2022 Completed Pre-Clinical Trials
11. Grant 01-Sep-2021 Completed Pre-Clinical Trials
10. Grant 15-Mar-2018 Completed Pre-Clinical Trials
9. Grant 01-Jan-2018 Completed Pre-Clinical Trials
8. Accelerator/Incubator 01-Jan-2017 Completed Pre-Clinical Trials
7. Grant 01-Jan-2017 Completed Pre-Clinical Trials
6. Grant 16-Sep-2016 Completed Pre-Clinical Trials
5. Grant 01-Jan-2016 $675K Completed Pre-Clinical Trials
4. Grant 01-Jan-2014 $1.5M Completed Pre-Clinical Trials
To view StemSynergy Therapeutics’s complete valuation and funding history, request access »

StemSynergy Therapeutics Patents

StemSynergy Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2025214920-A1 Compositions and methods for treating cancer and reducing wnt mediated effects Pending 02-Feb-2024
US-20250257061-A1 Compositions and methods for treating cancer and reducing wnt mediated effects Pending 02-Feb-2024
WO-2025166286-A1 Compositions and methods for treating cancer and reducing wnt mediated effects Pending 02-Feb-2024
AU-2021275994-A1 Notch inhibitors and uses thereof Inactive 21-May-2020
AU-2021276673-A1 Notch inhibitors and uses thereof Inactive 21-May-2020 C07D403/12
To view StemSynergy Therapeutics’s complete patent history, request access »

StemSynergy Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

StemSynergy Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government
QB3 Accelerator/Incubator
National Cancer Institute Government
U.S. Department of Health and Human Services Government
UM Ventures Venture Capital Minority
To view StemSynergy Therapeutics’s complete investors history, request access »

StemSynergy Therapeutics FAQs

  • When was StemSynergy Therapeutics founded?

    StemSynergy Therapeutics was founded in 2007.

  • Where is StemSynergy Therapeutics headquartered?

    StemSynergy Therapeutics is headquartered in Miami, FL.

  • What is the size of StemSynergy Therapeutics?

    StemSynergy Therapeutics has 6 total employees.

  • What industry is StemSynergy Therapeutics in?

    StemSynergy Therapeutics’s primary industry is Drug Discovery.

  • Is StemSynergy Therapeutics a private or public company?

    StemSynergy Therapeutics is a Private company.

  • What is StemSynergy Therapeutics’s current revenue?

    The current revenue for StemSynergy Therapeutics is .

  • Who are StemSynergy Therapeutics’s investors?

    National Institutes of Health, QB3, National Cancer Institute, U.S. Department of Health and Human Services, and UM Ventures have invested in StemSynergy Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process